Clinical Trials Browser

OTHER × Lymphoma, Large B-Cell, Diffuse × sintilimab × Clear all

NCT07077512 2026-01-21

Relmacabtagene Autoleucel Combined With Sintilimab for Relapsed/Refractory B-cell Lymphoma

Phase 2 Recruiting

Lymphoma, Follicular, Lymphoma, B-Cell, Lymphoma, Large B-Cell, Diffuse, Lymphoma, Mantle-Cell

NCT04659434 2020-12-09

Sintilimab Plus R-GemOx as Second-line Salvage Therapy in Patients With R/R DLBCL

Phase 2 Unknown

Lymphoma, Large B-Cell, Diffuse